C
Careium AB (publ)
STO:CARE
Careium AB (publ)
STO:CARE
Price:
20.8
SEK
1.96%
Market Closed
Market Cap:
kr506.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Careium AB (publ)
STO:CARE
|
SE |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
Merck & Co Inc
NYSE:MRK
|
US |
Income Statement
Earnings Waterfall
Careium AB (publ)
Careium AB (publ)
Income Statement
Careium AB (publ)
Careium AB (publ)
Currency: SEK
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
9
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
|
| Revenue |
913
N/A
|
940
+3%
|
1 116
+19%
|
725
-35%
|
741
+2%
|
780
+5%
|
821
+5%
|
825
+0%
|
841
+2%
|
857
+2%
|
841
-2%
|
871
+4%
|
867
0%
|
840
-3%
|
852
+1%
|
854
+0%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(542)
|
(565)
|
(680)
|
(451)
|
(461)
|
(476)
|
(484)
|
(484)
|
(486)
|
(496)
|
(489)
|
(497)
|
(492)
|
(472)
|
(476)
|
(479)
|
|
| Gross Profit |
371
N/A
|
376
+1%
|
437
+16%
|
274
-37%
|
279
+2%
|
304
+9%
|
338
+11%
|
341
+1%
|
355
+4%
|
361
+2%
|
352
-2%
|
374
+6%
|
376
+1%
|
368
-2%
|
376
+2%
|
375
0%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(381)
|
(378)
|
(457)
|
(290)
|
(263)
|
(287)
|
(282)
|
(281)
|
(284)
|
(282)
|
(278)
|
(290)
|
(295)
|
(298)
|
(309)
|
(326)
|
|
| Selling, General & Administrative |
(363)
|
(388)
|
(464)
|
(310)
|
(284)
|
(280)
|
(271)
|
(264)
|
(265)
|
(263)
|
(259)
|
(266)
|
(267)
|
(266)
|
(275)
|
(286)
|
|
| Research & Development |
(34)
|
(32)
|
(37)
|
(18)
|
(16)
|
(16)
|
(20)
|
(20)
|
(21)
|
(23)
|
(23)
|
(27)
|
(31)
|
(34)
|
(35)
|
(38)
|
|
| Other Operating Expenses |
16
|
43
|
44
|
38
|
37
|
9
|
9
|
2
|
2
|
4
|
4
|
4
|
3
|
1
|
1
|
(2)
|
|
| Operating Income |
(10)
N/A
|
(2)
+77%
|
(20)
-827%
|
(16)
+23%
|
16
N/A
|
17
+7%
|
56
+229%
|
59
+6%
|
71
+20%
|
78
+10%
|
74
-5%
|
84
+13%
|
81
-3%
|
70
-14%
|
67
-3%
|
49
-27%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
1
|
(0)
|
0
|
0
|
4
|
1
|
(5)
|
(8)
|
(16)
|
(14)
|
(5)
|
(13)
|
(11)
|
(12)
|
(13)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
|
| Pre-Tax Income |
(10)
N/A
|
(1)
+90%
|
(21)
-1 970%
|
(15)
+26%
|
17
N/A
|
22
+30%
|
58
+158%
|
53
-8%
|
63
+20%
|
62
-2%
|
60
-2%
|
78
+28%
|
69
-12%
|
59
-14%
|
55
-6%
|
35
-37%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(1)
|
4
|
8
|
7
|
(0)
|
(8)
|
(15)
|
(12)
|
(15)
|
(14)
|
(14)
|
(16)
|
(14)
|
(11)
|
(10)
|
1
|
|
| Income from Continuing Operations |
(11)
|
3
|
(13)
|
(9)
|
17
|
15
|
43
|
41
|
49
|
48
|
46
|
62
|
55
|
47
|
45
|
36
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(11)
N/A
|
3
N/A
|
(13)
N/A
|
(9)
+34%
|
17
N/A
|
15
-13%
|
43
+187%
|
41
-4%
|
49
+20%
|
47
-4%
|
45
-4%
|
58
+30%
|
52
-11%
|
45
-14%
|
42
-5%
|
33
-23%
|
|
| EPS (Diluted) |
-0.43
N/A
|
0.1
N/A
|
-0.54
N/A
|
-0.35
+35%
|
0.7
N/A
|
0.61
-13%
|
1.75
+187%
|
1.68
-4%
|
2.01
+20%
|
1.93
-4%
|
1.85
-4%
|
2.4
+30%
|
2.14
-11%
|
1.83
-14%
|
1.73
-5%
|
1.34
-23%
|
|
Switch to:
Switch to:
See Also
Discover More
